Peptoids are a new class of peptidomimetics that mimic the structure of AMPs, overcoming several of these drawbacks through resistance to proteolysis and efficient, low-cost synthesis of short sequences.
Abstract
Antimicrobial peptides (AMPs) have garnered interest as a promising therapeutic option due to their high potency against multidrug-resistant bacterial strains, primarily attributed to their amphiphilic cationic properties, which enable them to directly interact with bacterial cells via the negatively charged cell membrane, ultimately leading to bacterial cell death. The clinical use of AMPs is limited by cytotoxicity arising from poor selectivity between microbial and host membranes. Their susceptibility to enzymatic degradation and high manufacturing costs further constrain their use. These drawbacks of AMPs created an urgent need to find an alternative class of antibacterial molecules with enhanced structural features known as peptidomimetics. Peptoids are a new class of peptidomimetics that mimic the structure of AMPs, overcoming several of these drawbacks through resistance to proteolysis and efficient, low-cost synthesis of short sequences. This review provides a comprehensive overview of recent progress in the structure activity relationship of antibacterial peptoids, and critically evaluates how structural features influence biological outcomes.
The total synthesis of paenitracin B is reported, enabling definitive stereochemical validation of the previously proposed structure and delivering quantities of material suitable for more extensive antibacterial testing.
Yun-Hao Duan, Lucas Jongman, Vladyslav Lysenko et al.· ACS Infectious Diseases· 0 citations
While the peptide shows promising in vitro dual antibacterial and toxin-neutralizing capacity, its high sensitivity to proteinase K limits oral application.
En Liu, Wei-Ping Huo, Fu-Li Xu et al.· Applied Biochemistry and Bio...· 0 citations
Given the surge in antibiotic resistance, antimicrobial peptides have emerged as promising alternatives to conventional antibiotics; however, their therapeutic potential remains hindered by proteolytic instability and insufficient potency. Herein, we integrated an anti-proteolytic Arg-Pro scaffold with N-terminal fatty...
Jia-Jun Wang, Hao-Ran Xu, Yu Sun et al.· Cell Chemical Biology· 0 citations
Mechanistic study showed that 24a effectively inhibits biofilm formation and exerts its antibacterial effect by disrupting the bacterial cell membrane, paving the way for new strategies to combat antimicrobial resistance.
Qiong Wu, Bing-Yuan Yan, Chen Qu et al.· Chinese Journal of Natural M...· 0 citations
The growing occurrence of antimicrobial resistance represents a major challenge to global healthcare and necessitates the development of novel therapeutic agents capable of overcoming multidrug-resistant (MDR) pathogens. Gramicidin S (GS), a cyclic decapeptide antibiotic has attracted renewed interest as a promising te...
T. S. Shkuratova, Daria V. Andreeva, A. Tikhomirov et al.· Future Medicinal Chemistry· 0 citations
The optimized peptide G5P2 exhibits potent antibacterial activity via a typical membrane-disrupting mechanism, is not prone to inducing bacterial drug resistance, can synergize with traditional antibiotics to delay the emergence of antibiotic resistance, and has excellent in vivo antibacterial activity and high safety.
Pengyi Yan, Lan-Qing Hu, Bingqian Ren et al.· Journal of Medicinal Chemist...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.